XYLT2 and Miyoshi myopathy: Particularly, SHP2 acts as a key scaffold protein recruiting the GRB2/SOS complex and activates the RAS/ERK signal transduction pathway in many malignancies, including MM (Rehman et al., 2018; Ishibashi et al., 2020).